[The ergonovin test and drug therapy. Effect of Ca++ antagonists and nitrates during ergonovine provocation].
D000328:Adult; D000368:Aged; D000788:Angina Pectoris, Variant / Q000175:diagnosis* / Q000188:drug therapy; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000187:drug effects; D003329:Coronary Vasospasm / Q000175:diagnosis* / Q000188:drug therapy; D004874:Ergonovine; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007548:Isosorbide Dinitrate / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*
D011725:Pyridines; D009543:Nifedipine; D007548:Isosorbide Dinitrate; D004874:Ergonovine
Ergonovin-Test und medikamentöse Behandlung. Wirkung von Ca++-Antagonisten und Nitraten während der Ergonovin-Provokation.